Back to List View Graph View

L-glutamine

L-glutamine is the biologically active L-enantiomer of glutamine, a proteinogenic amino acid and one of the most abundant free amino acid in human tissues and circulation.

Where the papers sit

8 papers from the last 6 months study l-glutamine directly · updated from PubMed 28 Oct 2026

Those 8 do not share a common subject.

  • Glutamine appears across studies of macrophage senescence, cancer treatment toxicity, nutritional support, mitochondrial metabolism, liver disease and nanopore engineering. Individual findings address SLC1A5-dependent transport, chemotherapy-induced diarrhea, carbon-ion radiotherapy, osteoarthritis and hepatic encephalopathy. The topics share glutamine as a biological or therapeutic component but do not establish a common mechanism or clinical direction. No unified trend emerges from this heterogeneous group.

    8 papers

PARADIGM SHIFT

Glutamine metabolism is a macrophage-state control point rather than a uniformly beneficial nutrient

The partial-hepatectomy mouse model of liver regeneration and the oxidative-stress-, cisplatin-, and radiation-induced senescent-macrophage model of squamous cell carcinoma invasion show that glutamine handling can determine macrophage state and disease outcome, rather than simply supply a beneficial metabolic substrate 42678502Sep 42333921Jun. In liver regeneration, loss of macrophage SLC1A5 depletes intracellular glutamine, induces senescence and inflammation, reduces Gas6-dependent efferocytosis, and impairs hepatocyte proliferation; in squamous cell carcinoma, glutaminase-2-driven glutaminolysis in senescent macrophages increases IL-1β and promotes tumor invasion. Together, these findings replace a generic nutrient-support model with a context-dependent one in which macrophage glutamine metabolism is a therapeutic control point whose direction of manipulation must be determined by the macrophage state and disease.

NEW DIRECTION

L-glutamine is used as a single-molecule recognition target in an engineered biological nanopore

The ClyA nanopore and substrate-binding-domain protein system for single-molecule monitoring assigns L-glutamine a physical measurement role outside the set’s nutritional and disease-metabolism frameworks 42328825Jun. Instead of supplying cells, regulating metabolism, or serving as a therapeutic supplement, glutamine is the molecule whose recognition and conformationally dependent current signal are optimized by nanopore engineering, including a threefold signal amplification through tryptophan substitutions. This makes L-glutamine an analyte for real-time single-molecule sensing.

NEW DIRECTION

L-glutamine is treated as a toxic gut-liver-brain-axis metabolite to be neutralized

The engineered multi-strain bacterial cocktail for hepatic encephalopathy gives L-glutamine a pathogenic role that differs from the set’s usual use of it as a nutrient or metabolic support 42269583Jun. The therapy is described as simultaneously neutralizing ammonia and L-glutamine while replenishing essential amino acids, so the intervention seeks to remove glutamine rather than provide it or enhance its availability. This reframes glutamine as a target toxin in a microbiome-based treatment for cirrhosis-associated neuroinflammation.

L-glutamine chemical structure

Papers

The 8 papers from the last 6 months that study l-glutamine directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.

By theme

No clear themes (8)
  1. Solute Carrier Family 1 Member 5 (SLC1A5)-dependent glutamine transport regulates macrophage senescence and efferocytosis during liver regeneration. Molecular biomedicine · 1 Sept 2026 PMID 42678502
  2. The Preventive Effect of Introducing Glutamine on Chemotherapy-Induced Diarrhea in Colorectal Cancer and Its Influence on Inflammatory Factors Such as CRP and IL-6. Molecular nutrition & food research · 30 Jul 2026 PMID 42529890
  3. Forging New Pathways in Oncology: Strategic Insights from the 17th Annual Frontiers in Cancer Science Conference. Cancer research · 2 Jul 2026 PMID 42388021
  4. Outcomes of Supplementation With β-Hydroxy-β-methylbutyrate, Arginine, and Glutamine During Carbon-ion Radiotherapy for Head and Neck Cancer: A Prospective Exploratory Study. In vivo (Athens, Greece) · 30 Jun 2026 PMID 42379751
  5. Oxidative Stress Induced Senescent Macrophage-Driven Squamous Cell Carcinoma Invasion via Glutamine Metabolic Reprogramming. Aging cell · 23 Jun 2026 PMID 42333921
  6. Engineering a Biological Nanopore for Monitoring Protein Dynamics and Conformational Changes at the Single-Molecule Level. ACS nano · 22 Jun 2026 PMID 42328825
  7. Semaglutide targets muscle mitochondria to regulate glutamine metabolism and treat osteoarthritis. iScience · 17 Jun 2026 PMID 42305583
  8. Engineered probiotic for hepatic encephalopathy. Cell host & microbe · 10 Jun 2026 PMID 42269583

By study type

Observational studies and case reports (2)
  1. The Preventive Effect of Introducing Glutamine on Chemotherapy-Induced Diarrhea in Colorectal Cancer and Its Influence on Inflammatory Factors Such as CRP and IL-6. Molecular nutrition & food research · 30 Jul 2026 PMID 42529890
  2. Outcomes of Supplementation With β-Hydroxy-β-methylbutyrate, Arginine, and Glutamine During Carbon-ion Radiotherapy for Head and Neck Cancer: A Prospective Exploratory Study. In vivo (Athens, Greece) · 30 Jun 2026 PMID 42379751
Human data, design not indexed (1)
  1. Forging New Pathways in Oncology: Strategic Insights from the 17th Annual Frontiers in Cancer Science Conference. Cancer research · 2 Jul 2026 PMID 42388021
Preclinical: animal, cell and lab studies (4)
  1. Solute Carrier Family 1 Member 5 (SLC1A5)-dependent glutamine transport regulates macrophage senescence and efferocytosis during liver regeneration. Molecular biomedicine · 1 Sept 2026 PMID 42678502
  2. Oxidative Stress Induced Senescent Macrophage-Driven Squamous Cell Carcinoma Invasion via Glutamine Metabolic Reprogramming. Aging cell · 23 Jun 2026 PMID 42333921
  3. Engineering a Biological Nanopore for Monitoring Protein Dynamics and Conformational Changes at the Single-Molecule Level. ACS nano · 22 Jun 2026 PMID 42328825
  4. Engineered probiotic for hepatic encephalopathy. Cell host & microbe · 10 Jun 2026 PMID 42269583
Unclassified: not yet indexed with MeSH (1)
  1. Semaglutide targets muscle mitochondria to regulate glutamine metabolism and treat osteoarthritis. iScience · 17 Jun 2026 PMID 42305583